Westat has experience in a wide range of infectious disease and immunology studies involving adult, adolescent, and pediatric populations.
Since 1987, Westat has supported several large government-sponsored networks conducting Phase 1 to 4 clinical trials and observational studies. Many of these studies were conducted under investigational new drug (INDs) applications and implemented in collaboration with representatives from pharmaceutical and biotech sponsors.
Our infectious disease areas of expertise include HIV, respiratory infections, HPV, tuberculosis, malaria, influenza (H1N1, H5N1 [avian flu]), and hepatitis B, C, and G.
We provide specific support in